MLL
REGN icon

Moody Lynn & Lieberson’s Regeneron Pharmaceuticals REGN Stock Holding History

Moody Lynn & Lieberson’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,109
Closed -$2.4M – 277
2026
Q1 		$2.4M Sell
3,109
-241
-7% -$185K 0.13% 78
2025
Q4 		$2.59M Buy
+3,350
New +$2.28M 0.14% 77
2024
Q4 		– Sell
-267
Closed -$281K – 259
2024
Q3 		$281K Sell
267
-755
-74% -$840K 0.02% 217
2024
Q2 		$1.07M Sell
1,022
-3,553
-78% -$3.44M 0.07% 113
2024
Q1 		$4.4M Buy
4,575
+55
+1% +$52.3K 0.3% 60
2023
Q4 		$3.97M Buy
4,520
+4,253
+1,593% +$3.5M 0.3% 61
2023
Q3 		$220K Buy
+267
New +$210K 0.02% 197
2023
Q2 		– Sell
-4,265
Closed -$3.5M – 237
2023
Q1 		$3.5M Sell
4,265
-4
-0.1% -$3.02K 0.32% 65
2022
Q4 		$3.08M Sell
4,269
-5
-0.1% -$3.69K 0.28% 70
2022
Q3 		$2.94M Sell
4,274
-3,387
-44% -$2.13M 0.28% 66
2022
Q2 		$4.53M Sell
7,661
-384
-5% -$250K 0.41% 54
2022
Q1 		$5.62M Buy
+8,045
New +$5.09M 0.41% 51
2021
Q4 		– Sell
-6,467
Closed -$3.91M – 245
2021
Q3 		$3.91M Buy
+6,467
New +$4.01M 0.29% 73
2020
Q3 		– Sell
-9,108
Closed -$5.68M – 203
2020
Q2 		$5.68M Buy
9,108
+3,721
+69% +$2.11M 0.62% 42
2020
Q1 		$2.63K Sell
5,387
-6,557
-55% -$2.7M 0.36% 55
2019
Q4 		$4.49M Buy
+11,944
New +$4.02M 0.43% 67
2017
Q3 		– Sell
-4,170
Closed -$2.05M – 217
2017
Q2 		$2.05M Sell
4,170
-264
-6% -$116K 0.27% 71
2017
Q1 		$1.72M Buy
+4,434
New +$1.64M 0.24% 73
2016
Q2 		– Sell
-5,905
Closed -$2.13M – 163
2016
Q1 		$2.13M Buy
5,905
+2,223
+60% +$916K 0.34% 72
2015
Q4 		$2M Buy
3,682
+2,856
+346% +$1.55M 0.31% 77
2015
Q3 		$384K Sell
826
-10,130
-92% -$5.44M 0.07% 131
2015
Q2 		$5.59M Buy
+10,956
New +$5.35M 0.89% 45

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Moody Lynn & Lieberson's REGN Position: Q2 2026 in Review

Moody Lynn & Lieberson sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 3,109 shares — an estimated $2.4M sold.

Moody Lynn & Lieberson first reported a position in REGN in Q2 2015 and held it in 22 quarters. The position peaked at $5.68M in Q2 2020. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Moody Lynn & Lieberson reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 3,109 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.4M.
  • Moody Lynn & Lieberson first reported a position in Regeneron Pharmaceuticals in Q2 2015 and held it in 22 quarters.
  • Moody Lynn & Lieberson's Regeneron Pharmaceuticals position peaked at $5.68M in Q2 2020.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Moody Lynn & Lieberson's 13F filing for Q2 2026, filed 20 Jul 2026.